$167.95
0.48% yesterday
NYSE, May 08, 10:10 pm CET
ISIN
US0758871091
Symbol
BDX

Becton, Dickinson & Stock price

$167.95
-32.88 16.37% 1M
-63.69 27.50% 6M
-58.92 25.97% YTD
-65.63 28.10% 1Y
-84.25 33.41% 3Y
-80.15 32.31% 5Y
+29.50 21.31% 10Y
NYSE, Closing price Thu, May 08 2025
+0.81 0.48%
ISIN
US0758871091
Symbol
BDX
Sector

Key metrics

Market capitalization $48.14b
Enterprise Value $66.64b
P/E (TTM) P/E ratio 32.05
EV/FCF (TTM) EV/FCF 25.73
EV/Sales (TTM) EV/Sales 3.19
P/S ratio (TTM) P/S ratio 2.31
P/B ratio (TTM) P/B ratio 1.91
Dividend yield 2.26%
Last dividend (FY24) $3.80
Revenue growth (TTM) Revenue growth 5.84%
Revenue (TTM) Revenue $20.87b
EBIT (operating result TTM) EBIT $2.73b
Free Cash Flow (TTM) Free Cash Flow $2.59b
Cash position $763.00m
EPS (TTM) EPS $5.24
P/E forward 33.72
P/S forward 2.20
EV/Sales forward 3.05
Short interest 1.42%
Show more

Is Becton, Dickinson & a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.

Becton, Dickinson & Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Becton, Dickinson & forecast:

8x Buy
42%
11x Hold
58%

Analyst Opinions

19 Analysts have issued a Becton, Dickinson & forecast:

Buy
42%
Hold
58%

Financial data from Becton, Dickinson &

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
20,867 20,867
6% 6%
100%
- Direct Costs 11,553 11,553
0% 0%
55%
9,314 9,314
15% 15%
45%
- Selling and Administrative Expenses 3,113 3,113
33% 33%
15%
- Research and Development Expense 1,246 1,246
6% 6%
6%
4,955 4,955
7% 7%
24%
- Depreciation and Amortization 2,227 2,227
3% 3%
11%
EBIT (Operating Income) EBIT 2,728 2,728
11% 11%
13%
Net Profit 1,519 1,519
14% 14%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Becton, Dickinson & directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Becton, Dickinson & Stock News

Positive
Seeking Alpha
3 days ago
The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kings, including Altria and Canadian Utilities, are now fairly priced, with annual dividends from $1K investments exceeding their single-share prices. Analysts predict net gains of 14.7% to 56.86% for...
Positive
Seeking Alpha
7 days ago
I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-volatility aristocrats offer a 3.4% yield, a 46% downside capture ratio, and 52% less volatility than the S&P, making them ideal for addressing recession concerns while still providing a 23% return. ...
Negative
Market Watch
8 days ago
Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research instrument sales.
More Becton, Dickinson & News

Company Profile

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

Head office United States
CEO Thomas Polen
Employees 74,000
Founded 1897
Website www.bd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today